New drug approvals - January 2024
|
Product Name
|
GENCEBOK SOLUTION FOR INFUSION 10MG/ML
|
|
Active Ingredient (Strength)
|
Caffeine Citrate(10.00mg/ml)
|
|
Application type
|
NDA-2
|
|
Product Registrant
|
AXXESSBIO PTE. LTD.
|
|
Date of Approval
|
16/01/2024
|
|
Registration No.
|
SIN16929P
|
|
Indications:
Treatment of primary apnoea of premature newborns.
|
|
Product Name
|
LUMIGAN PF (BIMATOPROST OPHTHALMIC SOLUTION) 0.03%
|
|
Active Ingredient (Strength)
|
Bimatoprost(0.3 mg/mL)
|
|
Application type
|
NDA-2
|
|
Product Registrant
|
ABBVIE PTE. LTD.
|
|
Date of Approval
|
30/01/2024
|
|
Registration No.
|
SIN16938P
|
|
Indications:
LUMIGAN® Preservative Free 0.03% (bimatoprost ophthalmic solution) is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.
|
Healthcare professional, Industry member, Therapeutic Products
Published:
New Drug Approvals